These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Significance of maternal screening for toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infection in cases of fetal growth restriction. Yamamoto R; Ishii K; Shimada M; Hayashi S; Hidaka N; Nakayama M; Mitsuda N J Obstet Gynaecol Res; 2013 Mar; 39(3):653-7. PubMed ID: 23107457 [TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and clinical aspects of the TORCHES syndrome]. Oranje AP; Dumas AM; Sluiters JF; Fetter WP; Dzoljic-Danilovic G; Stolz E Ned Tijdschr Geneeskd; 1986 May; 130(19):858-61. PubMed ID: 3012377 [No Abstract] [Full Text] [Related]
6. [Congenital infections caused by TORCH agents]. Fabris C; Mombrò M; Lio C Pediatr Med Chir; 1986; 8(4):443-52. PubMed ID: 3033613 [TBL] [Abstract][Full Text] [Related]
7. Investigation of congenital infection--the TORCH screen is not a legitimate test. Paediatric Infectious Diseases Group of the Australasian Society for Infectious Diseases. Garland SM; Gilbert GL Med J Aust; 1993 Sep; 159(5):346-8. PubMed ID: 8395645 [No Abstract] [Full Text] [Related]
8. TORCH serologies and specific IgM antibody determination in acquired and congenital infections. Fung JC; Tilton RC Ann Clin Lab Sci; 1985; 15(3):204-11. PubMed ID: 2986514 [TBL] [Abstract][Full Text] [Related]
9. Is routine TORCH screening and urine CMV culture warranted in small for gestational age neonates? van der Weiden S; de Jong EP; Te Pas AB; Middeldorp JM; Vossen AC; Rijken M; Walther FJ; Lopriore E Early Hum Dev; 2011 Feb; 87(2):103-7. PubMed ID: 21145674 [TBL] [Abstract][Full Text] [Related]
10. Current concepts of infectious diseases in the newborn infant. Klein JO Adv Pediatr; 1984; 31():405-46. PubMed ID: 6097103 [No Abstract] [Full Text] [Related]
11. [The TORCH study. A reevaluation]. Holtmon LW; Hansen TW; Holter E Tidsskr Nor Laegeforen; 1994 Jan; 114(3):311-2. PubMed ID: 8191426 [TBL] [Abstract][Full Text] [Related]
12. ELISA and TORCH complex: a comparison with the customary tests. Ferrucci M; Zavarini A Quad Sclavo Diagn; 1982 Sep; 18(3):258-67. PubMed ID: 6306715 [No Abstract] [Full Text] [Related]
13. [Analysis of serological findings and clinical manifestations of TORCH infections in newborns]. Wang L; Li KH; Liu H; Liu JY; Li YJ Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):283-4. PubMed ID: 15340579 [TBL] [Abstract][Full Text] [Related]
14. Serological studies on possible causes of intra-uterine infections in Thai infants. Tantivanich S; Savanat T; Vongsthongsri U; Manesuwan P Southeast Asian J Trop Med Public Health; 1980 Sep; 11(3):387-94. PubMed ID: 6255610 [TBL] [Abstract][Full Text] [Related]
15. Should we expand the TORCH complex? A description of clinical and diagnostic aspects of selected old and new agents. Kinney JS; Kumar ML Clin Perinatol; 1988 Dec; 15(4):727-44. PubMed ID: 2850128 [TBL] [Abstract][Full Text] [Related]
16. Screening small for gestational age babies for congenital infection. Primhak RA; Simpson RM Clin Pediatr (Phila); 1982 Jul; 21(7):417-20. PubMed ID: 6282523 [TBL] [Abstract][Full Text] [Related]
17. Intrauterine infections: a literature review. França CM; Mugayar LR Spec Care Dentist; 2004; 24(5):250-3. PubMed ID: 15552342 [TBL] [Abstract][Full Text] [Related]
18. Torch agents in neonates and in infants in Turkey. Kanra G; Gürses N; Seçmeer G; Unal M; Günalp A Turk J Pediatr; 1979 Jan; 21(1):4-6. PubMed ID: 232791 [No Abstract] [Full Text] [Related]
19. [TORCH infections in mothers as a cause of neonatal morbidity]. Mladina N; Mehikić G; Pasić A Med Arh; 2000; 54(5-6):273-6. PubMed ID: 11219902 [TBL] [Abstract][Full Text] [Related]